skin cancer
As the incidence of both non-melanoma and melanoma skin cancers has been increasing over the past decades, better treatment modalities are needed.
vda-1102
VDA-1102 ointment is the FIRST in a new class of drugs that selectively targets malignant skin cancer cells with minimal effects on surrounding healthy skin.
technology spotlight
HK2 has a vital role in cancer metabolism. Vidac is creating innovative therapies for people suffering from a range of oncology and dermatology ailments.
skin cancer
As the incidence of both non-melanoma and melanoma skin cancers has been increasing over the past decades, better treatment modalities are needed.
vda-1102
VDA-1102 ointment is the FIRST in a new class of drugs that selectively targets malignant skin cancer cells with minimal effects on surrounding healthy skin.
technology spotlight
HK2 has a vital role in cancer metabolism. Vidac is creating innovative therapies for people suffering from a range of oncology and dermatology ailments.

Science: HK2 - A Major Driver of Cancer

cancerdriver

VDA-1102 VDAC/HK2 MOA

HKS N-terminal-helix flips out of place to allow VDAC's N-terminal-helix to replace it, thus binding the two proteins.
cancerdriver

VDA-1102 Inhibits Cancer Proliferation

VDA-1102 demonstrated strong inhibition of cancer growth across multiple indications.

70% of a panel with 57 cancer models (2019-2021)

Threshold <2uM; Colony forming assay in 57 patient-derived tumors and cancer cell lines conducted at Oncotest GmbH, a division of Charles River Labs.

Pipeline

Vidac has built a portfolio of novel product candidates that target significant unmet medical needs in oncology and dermatology.

read more

Pipeline

Vidac hat ein Portfolio von Produktkandidaten aufgebaut, die einen erheblichen ungedeckten medizinischen Bedarf decken. Das Wertversprechen dieser neuartigen Medikamente beruht auf einem einzigartigen Wirkmechanismus, der Dermatologen, Onkologen und Patienten sowohl Wirksamkeit als auch Verträglichkeit bietet.

weiterlesen

Therapeutic Areas

Vidac is creating innovative therapies for people suffering from a range of oncologic and dermatologic medical conditions.

read more